Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy
Frontiers in Pediatrics · 21.07.2026 · 14
DOI: 10.3389/fped.2026.1879540 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 21.07.2026. Verfasst von Ai Yamada und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Transplant-associated thrombotic microangiopathy (TA-TMA) is a life-threatening complication of hematopoietic stem cell transplantation (HSCT). Previous reports in the United States have suggested that TA-TMA is caused by complement-related genetic variants. However, these findings need to be validated in other countries and ethnic populations.
Methods
We performed targeted sequencing of 40 complement-and coagulopathy-related genes in 44 Japanese pediatric patients who underwent HSCT, including 20 patients with TA-TMA and 24 patients without TA-TMA. Seventeen genes reported to be related to TA-TMA were included. Additionally, 23 genes that are thought to be associated with complement system activation and coagulopathy were investigated. CFHR 1 /CFHR 3 deletions were also examined using multiplex ligation-dependent probe amplification.
Results
There was no significant difference in the percentage of patients bearing genetic variants between patients with and without TA-TMA. Furthermore, no marked differences in the percentage of patients or the average number of rare variants per patient were found between the two groups. Although we identified several rare non-synonymous variants in TA-TMA patients, we did not find any known pathogenic variants causing TA-TMA. Interestingly, a novel rare genetic variant in the C 1 r-like protein (C 1 RL) gene was identified in a patient with neuroblastoma who had undergone autologous HSCT, potentially associated with TA-TMA.
Conclusion
In this limited number of Japanese pediatric cohort with TA-TMA, we could not find an enrichment of rare variants among 40 complement- and coagulopathy-related genes. A novel, rare variant of C 1 RL was identified in a single patient with TA-TMA. Further studies with larger cohorts are necessary to clarify the genetic association in Japanese patients with TA-TMA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatrics, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
- Department of Pediatrics, Kindai University Hospital, Osaka, Japan.
- Department of Pediatrics, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
- Department of Hematology/Oncology, Hyogo Prefectural Kobe Children's Hospital, Hyogo, Japan.
- Department of Pediatrics, Kagoshima University School of Medical and Dental Science, Kagoshima, Japan.
- Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan.
Zitieren
APA
Yamada, A., Nagasawa, S., Nakagawa, M., Kamimura, S., Sakata, N., Nakayama, H., Hasegawa, D., Okamoto, Y., Takeuchi, M., Ohara, O., & Moritake, H. (2026). Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1879540
Vancouver
Yamada A, Nagasawa S, Nakagawa M, Kamimura S, Sakata N, Nakayama H, et al. Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1879540
BibTeX
@article{Yamada2026,
author = {Yamada, Ai and Nagasawa, Shun and Nakagawa, Midori and Kamimura, Sachiyo and Sakata, Naoki and Nakayama, Hideki and Hasegawa, Daiichiro and Okamoto, Yasuhiro and Takeuchi, Masanobu and Ohara, Osamu and Moritake, Hiroshi},
title = {Complement-related genetic analysis for Japanese children with transplant-associated thrombotic microangiopathy},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1879540}
}
EUVIMED